These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Donor-specific B and T lymphocyte antibodies and kidney graft survival. Jeannet M; Benzonana G; Arni I Transplantation; 1981 Mar; 31(3):160-3. PubMed ID: 7015609 [TBL] [Abstract][Full Text] [Related]
7. The relationship between flow cytometer crossmatch results and subsequent rejection episodes in cadaver renal allograft recipients. Lazda VA; Pollak R; Mozes MF; Jonasson O Transplantation; 1988 Mar; 45(3):562-5. PubMed ID: 3279580 [TBL] [Abstract][Full Text] [Related]
8. No advantage of flow cytometry crossmatch over complement-dependent cytotoxicity in immunologically well-documented renal allograft recipients. Christiaans MH; Overhof R; ten Haaft A; Nieman F; van Hooff JP; van den Berg-Loonen EM Transplantation; 1996 Nov; 62(9):1341-7. PubMed ID: 8932282 [TBL] [Abstract][Full Text] [Related]
9. Long-term graft survival is improved in cadaveric renal retransplantation by flow cytometric crossmatching. Bryan CF; Baier KA; Nelson PW; Luger AM; Martinez J; Pierce GE; Ross G; Shield CF; Warady BA; Aeder MI; Helling TS; Muruve N Transplantation; 1998 Dec; 66(12):1827-32. PubMed ID: 9884283 [TBL] [Abstract][Full Text] [Related]
10. The flow cytometric crossmatch and early renal transplant loss. Mahoney RJ; Ault KA; Given SR; Adams RJ; Breggia AC; Paris PA; Palomaki GE; Hitchcox SA; White BW; Himmelfarb J Transplantation; 1990 Mar; 49(3):527-35. PubMed ID: 2138366 [TBL] [Abstract][Full Text] [Related]
11. Positive remote crossmatch: impact on short-term and long-term outcome in cadaver renal transplantation. Noreen HJ; McKinley DM; Gillingham KJ; Matas AJ; Segall M Transplantation; 2003 Feb; 75(4):501-5. PubMed ID: 12605118 [TBL] [Abstract][Full Text] [Related]
12. Cadaveric renal transplantation with quadruple immunosuppression in patients with a positive antiglobulin crossmatch. Stratta RJ; Mason B; Lorentzen DF; Sollinger HW; D'Alessandro AM; Pirsch JD; Kalayoglu M; Belzer FO Transplantation; 1989 Feb; 47(2):282-6. PubMed ID: 2645713 [TBL] [Abstract][Full Text] [Related]
13. Antibodies to donor B lymphocytes and mixed lymphocyte culture blocking in cadaveric renal transplantation. Ettenger RB; Opelz G; Walker J; Terasaki PI; Uittenbogaart C; Pennisi AJ; Malekzadeh MH; Fine RN Transplantation; 1978 Apr; 25(4):169-72. PubMed ID: 147530 [TBL] [Abstract][Full Text] [Related]
15. Relationship of B cell alloantibodies to renal allograft survival. Mohanakumar T; Giedlin MA; Rhodes CL; DuVall CH; Mendez-Picon G; Kaplan AM; Lee HM Transplantation; 1979 Apr; 27(4):273-8. PubMed ID: 375503 [TBL] [Abstract][Full Text] [Related]
16. Specificity and Ig class of preformed alloantibodies causing a positive crossmatch in renal transplantation. The implications for graft survival. ten Hoor GM; Coopmans M; Allebes WA Transplantation; 1993 Aug; 56(2):298-304. PubMed ID: 7689256 [TBL] [Abstract][Full Text] [Related]
17. Renal graft survival is not influenced by a positive flow B-cell crossmatch. Bryan CF; Wakefield M; Reese JC; Shield CF; Warady BA; Winklhofer FT; Murillo D Clin Transplant; 2007; 21(1):72-9. PubMed ID: 17302594 [TBL] [Abstract][Full Text] [Related]
18. Living-donor liver transplantation at the University of Tokyo, 1996-2011: the impact of HLA matching and a positive crossmatch on long-term survival and tolerance. Waki K; Sugawara Y; Mizuta K; Fujita H; Kadowaki T; Kokudo N Clin Transpl; 2011; ():223-35. PubMed ID: 22755416 [TBL] [Abstract][Full Text] [Related]
19. Crossmatching with B and T cells and flow cytometry. Iwaki Y; Lau M; Cook DJ; Takemoto S; Terasaki PI Clin Transpl; 1986; ():277-84. PubMed ID: 3154417 [TBL] [Abstract][Full Text] [Related]
20. Analysis of positive kidney, heart, and liver transplant crossmatches reported to the Collaborative Transplant Study. Opelz G; Döhler B; Süsal C Hum Immunol; 2009 Aug; 70(8):627-30. PubMed ID: 19375469 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]